BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26062958)

  • 1. Increased Prevalence of Advanced Liver Fibrosis in Patients with Psoriasis: A Cross-sectional Analysis from the Rotterdam Study.
    van der Voort EA; Koehler EM; Nijsten T; Stricker BH; Hofman A; Janssen HL; Schouten JN; Wakkee M
    Acta Derm Venereol; 2016 Feb; 96(2):213-7. PubMed ID: 26062958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study.
    van der Voort EA; Koehler EM; Dowlatshahi EA; Hofman A; Stricker BH; Janssen HL; Schouten JN; Nijsten T
    J Am Acad Dermatol; 2014 Mar; 70(3):517-24. PubMed ID: 24373781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis.
    Gisondi P; Barba E; Girolomoni G
    J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):282-7. PubMed ID: 26537011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.
    Wong VW; Chu WC; Wong GL; Chan RS; Chim AM; Ong A; Yeung DK; Yiu KK; Chu SH; Woo J; Chan FK; Chan HL
    Gut; 2012 Mar; 61(3):409-15. PubMed ID: 21846782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.
    Doycheva I; Cui J; Nguyen P; Costa EA; Hooker J; Hofflich H; Bettencourt R; Brouha S; Sirlin CB; Loomba R
    Aliment Pharmacol Ther; 2016 Jan; 43(1):83-95. PubMed ID: 26369383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany.
    Labenz C; Huber Y; Kalliga E; Nagel M; Ruckes C; Straub BK; Galle PR; Wörns MA; Anstee QM; Schuppan D; Schattenberg JM
    Aliment Pharmacol Ther; 2018 Nov; 48(10):1109-1116. PubMed ID: 30288767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study.
    Chavez-Tapia NC; Sanchez-Jimenez BA; Vidaña-Perez D; Corrales-Rosas B; Balderas-Garces B; Vera-Izaguirre D; Santa Cruz FJ; Maldonado-Garcia C; Juarez-Hernandez E; Uribe M
    PLoS One; 2024; 19(4):e0290632. PubMed ID: 38626012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?
    Pongpit J; Porntharukchareon S; Kaewduang P; Promson K; Stitchantrakul W; Petraksa S; Thakkinstian A; Kositchaiwat C; Rajatanavin N; Sobhonslidsuk A
    Biomed Res Int; 2016; 2016():7963972. PubMed ID: 27006950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors.
    Prasetya IB; Hasan I; Wisnu W; Rumende CM
    Acta Med Indones; 2017 Apr; 49(2):91-98. PubMed ID: 28790222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
    Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with significant liver fibrosis assessed using transient elastography in general population.
    You SC; Kim KJ; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Lee WJ; Han KH
    World J Gastroenterol; 2015 Jan; 21(4):1158-66. PubMed ID: 25632188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy.
    Myers RP; Crotty P; Pomier-Layrargues G; Ma M; Urbanski SJ; Elkashab M
    Liver Int; 2010 Nov; 30(10):1471-80. PubMed ID: 20807336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver and advanced fibrosis in the elderly: Results from a community-based Polish survey.
    Hartleb M; Barański K; Zejda J; Chudek J; Więcek A
    Liver Int; 2017 Nov; 37(11):1706-1714. PubMed ID: 28489307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people.
    Jongraksak T; Sobhonslidsuk A; Jatchavala J; Warodomwichit D; Kaewduang P; Sungkanuparph S
    Int J STD AIDS; 2021 Mar; 32(3):266-275. PubMed ID: 33334267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid Function and the Risk of Nonalcoholic Fatty Liver Disease: The Rotterdam Study.
    Bano A; Chaker L; Plompen EP; Hofman A; Dehghan A; Franco OH; Janssen HL; Darwish Murad S; Peeters RP
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3204-11. PubMed ID: 27270473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and female gender, but not methotrexate, are the important associations of significant liver fibrosis in patients with moderate-to-severe psoriasis as detected by transient elastography.
    Mahajan R; Dogra S; Handa S; Razmi TM; Narang T; Rathi S; Dhiman RK; Saikia B; Karim A
    Indian J Dermatol Venereol Leprol; 2020; 86(6):649-655. PubMed ID: 32643632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease duration and Medsger's severity score are associated with significant liver fibrosis in patients with systemic sclerosis.
    Lee SW; Kim BK; Park JY; Kim DY; Ahn SH; Song JJ; Park YB; Lee SK; Han KH; Kim SU
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S68-74. PubMed ID: 26243041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence in vulnerable population of liver fibrosis identified by transient elastography.
    Chávez-Tapia N; Torres-Sánchez J; Romero-Flores J; Álvarez-Quiroz P; Ramírez-Álvarez S; Juárez-Hernández E; Pérez-Jáuregui J; Méndez-Sánchez N; Uribe M
    Ann Hepatol; 2015; 14(4):524-30. PubMed ID: 26019039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of significant hepatic fibrosis using magnetic resonance elastography in a health check-up clinic population.
    Kang KA; Jun DW; Kim MS; Kwon HJ; Nguyen MH
    Aliment Pharmacol Ther; 2020 Feb; 51(3):388-396. PubMed ID: 31943268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients.
    Pineda JA; González J; Ortega E; Tural C; Macías J; Griffa L; Burgos A;
    J Viral Hepat; 2010 Oct; 17(10):714-9. PubMed ID: 20002560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.